SunOpta Announces Fourth Quarter and Fiscal 2021 Financial Results
SunOpta reported Q4 2021 revenues of $204.2 million, down 0.6%, with plant-based revenue increasing 5.8% but fruit-based revenue declining 9.4%. Gross margin decreased to 9.0% from 15.5% due to production and labor challenges. The company recorded a loss of $1.9 million from continuing operations, significantly improved from $34.3 million last year. Adjusted EBITDA fell 48.2% to $10.7 million. For FY 2022, SunOpta forecasts revenue between $890 million and $930 million and adjusted EBITDA between $67 million and $75 million, signaling optimism for recovery in profitability.
- Plant-based revenue increased 5.8% year-over-year in Q4 2021.
- Loss from continuing operations improved to $1.9 million from $34.3 million in Q4 2020.
- Revenue guidance for FY 2022 is $890 million - $930 million, indicating growth expectations.
- Q4 2021 gross margin decreased by 650 basis points to 9.0%, primarily due to labor productivity and raw material challenges.
- Fruit-based revenue declined 9.4%, contributing to overall revenue decrease.
Plant-based Q4 revenue increased
Fiscal year 2021 Plant-based revenue increased
Strong sequential revenue and gross profit growth expected in Q1, 2022
All amounts are expressed in
Fourth quarter 2021 highlights:
-
Revenues of
$204.2 million 0.6% reflecting5.8% growth in plant-based offset by a9.4% decline in fruit-based. Adjusting for the 53rd week in fiscal 2020, consolidated revenue growth was2.5% . -
Gross margin decreased 650 basis points to
9.0% from15.5% in the prior year, primarily reflecting production shortfalls and yield factors stemming from labor productivity and raw material challenges. -
Loss from continuing operations was
$1.9 million $34.3 million -
Adjusted loss¹ attributable to common shareholders was
$1.0 million $0.01 $2.5 million $0.03 -
Adjusted EBITDA¹ of
$10.7 million 5.2% of revenues for the fourth quarter of 2021, was down48.2% versus$20.6 million 10.0% of revenues in the fourth quarter of 2020.
“Fourth quarter results were hampered by issues stemming from challenges in the macro environment. We had unexpected and therefore unrecovered inflation, yield related losses in fruit and higher costs in our plants without a corresponding increase in production. While staffing levels recovered in the fourth quarter, we were focused on training 90+ new employees, incurring all the costs but lacking the corresponding production volume. The good news is that we are seeing production quickly returning to more normal levels in the first quarter of 2022. In addition to labor productivity initiatives, pricing actions and our capacity expansion in Allentown all point to a solid recovery in profitability from our fourth quarter of 2021 levels, starting in the first quarter of 2022. Plant-based revenue rose
Fourth Quarter 2021 Results
Revenues of
Gross profit was
Segment operating loss¹ was
Adjusted EBITDA¹ was
Loss from continuing operations attributable to common shareholders for the fourth quarter of 2021 was
Adjusted loss¹ in the fourth quarter of 2021 was
Please refer to the discussion and table below under “Non-GAAP Measures”.
Balance Sheet and Cash Flow
As of
2022 Outlook2
Consolidated revenue range:
Consolidated adjusted EBITDA1 range:
Conference Call
1 See discussion of non-GAAP measures
2 The Company has included certain forward-looking statements about the future financial performance that include non-GAAP financial measures, including Adjusted EBITDA. These non–GAAP financial measures are derived by excluding certain amounts, expenses or income, from the corresponding financial measures determined in accordance with GAAP. The determination of the amounts that are excluded from these non-GAAP financial measures is a matter of management judgment and depends upon, among other factors, the nature of the underlying expense or income amounts recognized in a given period. We are unable to present a quantitative reconciliation of the aforementioned forward-looking non-GAAP financial measures to their most directly comparable forward-looking GAAP financial measures because management cannot reliably predict all of the necessary components of such GAAP measures. Historically, management has excluded the following items from certain of these non-GAAP measures, and such items may also be excluded in future periods and could be significant amounts.
- Expenses related to the acquisition or divestiture of a business, including business development costs, impairment of assets, integration costs, severance, retention costs and transaction costs;
- Start-up costs of new facilities and equipment;
- Charges associated with restructuring and cost saving initiatives, including but not limited to asset impairments, accelerated depreciation, severance costs and lease abandonment charges;
- Asset impairment charges and facility closure costs;
- Legal settlements or awards; and
- The tax effect of the above items.
About
Forward-Looking Statements
Certain statements included in this press release may be considered "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation, which are based on information available to us on the date of this release. These forward-looking statements include, but are not limited to, our belief that profitability will recover starting in Q1 2022, our 4th aseptic plant will enable accelerated revenue and profit growth in 2023 and plant-based revenue and profits will double in the coming years, as well as our anticipated consolidated revenue and adjusted EBITDA ranges for fiscal 2022. Generally, forward-looking statements do not relate strictly to historical or current facts and are typically accompanied by words such as “expected”, “point to”, “continued”, “well-positioned”, “believe”, “anticipate”, “estimates”, “can”, “will”, “target”, "should", "would", "plans", "becoming", "intend", "confident", "may", "project", "potential", "intention", "might", "predict", “budget”, “forecast” or other similar terms and phrases intended to identify these forward-looking statements. Forward-looking statements are based on information available to the Company on the date of this release and are based on estimates and assumptions made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments including, but not limited to, the Company’s actual financial results; the factors identified in footnote 2 above, uninterrupted operations and service levels to our customers during COVID-19; current customer demand for the Company’s products, particularly our plant-based products; general economic conditions; continued consumer interest in health and wellness; the Company’s ability to maintain product pricing levels; planned facility and operational expansions, closures and divestitures; cost rationalization and product development initiatives; alternative potential uses for the Company’s capital resources; portfolio optimization and productivity efforts; the sustainability of the Company’s sales pipeline; the Company’s expectations regarding commodity pricing, margins and hedging results; improved availability and field prices for fruit; procurement and logistics savings; freight lane cost reductions; yield and throughput enhancements; and labor cost reductions. Whether actual timing and results will agree with expectations and predictions of the Company is subject to many risks and uncertainties including, but not limited to, potential loss of suppliers and customers as well as supply chain, logistics and other disruptions resulting from or related to COVID-19; unexpected issues or delays with completion of our 4th aseptic plant or the Company’s structural improvements and automation investments; failure or inability to implement portfolio changes, process improvements, go-to-market improvements and process sustainability strategies in a timely manner; changes in the level of capital investment; local and global political and economic conditions; consumer spending patterns and changes in market trends; decreases in customer demand; delayed or unsuccessful product development efforts; potential product recalls; working capital management; availability and pricing of raw materials and supplies; potential covenant breaches under the Company’s credit facilities; and other risks described from time to time under "Risk Factors" in the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q (available at www.sec.gov). Consequently, all forward-looking statements made herein are qualified by these cautionary statements and there can be no assurance that the actual results or developments anticipated by the Company will be realized. The Company undertakes no obligation to publicly correct or update the forward-looking statements in this document, in other documents, or on its website to reflect future events or circumstances, except as may be required under applicable securities laws.
|
||||||||
Consolidated Statements of Operations |
||||||||
For the quarters and years ended |
||||||||
(Unaudited) |
||||||||
(All dollar amounts expressed in thousands of |
||||||||
|
|
|
|
|
||||
|
Quarter ended |
Year ended |
||||||
|
|
|
|
|
||||
|
$ |
$ |
$ |
$ |
||||
|
|
|
|
|
||||
Revenues |
204,232 |
|
205,556 |
|
812,624 |
|
789,213 |
|
|
|
|
|
|
||||
Cost of goods sold |
185,828 |
|
173,749 |
|
714,539 |
|
680,136 |
|
|
|
|
|
|
||||
Gross profit |
18,404 |
|
31,807 |
|
98,085 |
|
109,077 |
|
|
|
|
|
|
||||
Selling, general and administrative expenses |
16,793 |
|
25,590 |
|
76,874 |
|
89,463 |
|
Intangible asset amortization |
2,612 |
|
2,194 |
|
9,950 |
|
8,946 |
|
Other expense, net |
1,442 |
|
22,604 |
|
8,890 |
|
23,393 |
|
Foreign exchange loss (gain) |
579 |
|
(2,790 |
) |
1,112 |
|
(1,640 |
) |
|
|
|
|
|
||||
Earnings (loss) from continuing operations before the following |
(3,022 |
) |
(15,791 |
) |
1,259 |
|
(11,085 |
) |
|
|
|
|
|
||||
Interest expense, net |
2,624 |
|
7,605 |
|
8,769 |
|
30,042 |
|
Loss on retirement of debt |
- |
|
8,915 |
|
- |
|
8,915 |
|
|
|
|
|
|
||||
Loss from continuing operations before income taxes |
(5,646 |
) |
(32,311 |
) |
(7,510 |
) |
(50,042 |
) |
|
|
|
|
|
||||
Income tax expense (benefit) |
(3,782 |
) |
2,019 |
|
(3,366 |
) |
(2,740 |
) |
|
|
|
|
|
||||
Loss from continuing operations |
(1,864 |
) |
(34,330 |
) |
(4,144 |
) |
(47,302 |
) |
|
|
|
|
|
||||
Earnings from discontinued operations |
- |
|
107,391 |
|
- |
|
124,820 |
|
|
|
|
|
|
||||
Net earnings (loss) |
(1,864 |
) |
73,061 |
|
(4,144 |
) |
77,518 |
|
|
|
|
|
|
||||
Dividends and accretion on preferred stock |
(752 |
) |
(2,855 |
) |
(4,197 |
) |
(10,328 |
) |
|
|
|
|
|
||||
Earnings (loss) attributable to common shareholders |
(2,616 |
) |
70,206 |
|
(8,341 |
) |
67,190 |
|
|
|
|
|
|
||||
Basic and diluted earnings (loss) per share |
|
|
|
|
||||
From continuing operations |
(0.02 |
) |
(0.41 |
) |
(0.08 |
) |
(0.65 |
) |
From discontinued operations |
- |
|
1.19 |
|
- |
|
1.40 |
|
Basic and diluted earnings (loss) per share |
(0.02 |
) |
0.78 |
|
(0.08 |
) |
0.75 |
|
|
|
|
|
|
||||
Weighted-average common shares outstanding (000s) |
|
|
|
|
||||
Basic |
107,341 |
|
89,991 |
|
104,098 |
|
89,234 |
|
Diluted |
107,341 |
|
89,991 |
|
104,098 |
|
89,234 |
|
|
||||
Consolidated Balance Sheets |
||||
As at |
||||
(Unaudited) |
||||
(All dollar amounts expressed in thousands of |
||||
|
|
|
||
|
|
|
||
|
$ |
$ |
||
|
|
|
||
ASSETS |
|
|
||
Current assets |
|
|
||
Cash and cash equivalents |
227 |
|
251 |
|
Accounts receivable |
84,702 |
|
72,724 |
|
Inventories |
220,143 |
|
147,748 |
|
Prepaid expenses and other current assets |
16,638 |
|
21,665 |
|
Current income taxes recoverable |
8,259 |
|
6,935 |
|
Total current assets |
329,969 |
|
249,323 |
|
|
|
|
||
Property, plant and equipment, net |
219,537 |
|
158,048 |
|
Operating lease right-of-use assets |
47,245 |
|
35,172 |
|
Intangible assets, net |
148,440 |
|
133,317 |
|
|
3,998 |
|
3,998 |
|
Other assets |
5,930 |
|
5,757 |
|
|
|
|
||
Total assets |
755,119 |
|
585,615 |
|
|
|
|
||
LIABILITIES |
|
|
||
Current liabilities |
|
|
||
Accounts payable and accrued liabilities |
121,430 |
|
118,592 |
|
Income taxes payable |
- |
|
1,431 |
|
Current portion of long-term debt |
9,760 |
|
3,478 |
|
Current portion of operating lease liabilities |
12,203 |
|
12,750 |
|
Current portion of long-term liabilities |
- |
|
200 |
|
Total current liabilities |
143,393 |
|
136,451 |
|
|
|
|
||
Long-term debt |
214,843 |
|
66,245 |
|
Operating lease liabilities |
39,028 |
|
24,582 |
|
Long-term liabilities |
2,241 |
|
- |
|
Deferred income taxes |
22,485 |
|
25,408 |
|
Total liabilities |
421,990 |
|
252,686 |
|
|
|
|
||
Series A Preferred Stock |
- |
|
87,305 |
|
Series B-1 Preferred Stock |
28,145 |
|
27,595 |
|
|
|
|
||
EQUITY |
|
|
||
|
|
|
||
Common shares |
436,463 |
|
326,545 |
|
Additional paid-in capital |
23,240 |
|
37,862 |
|
Accumulated deficit |
(156,082 |
) |
(147,741 |
) |
Accumulated other comprehensive income |
1,363 |
|
1,363 |
|
Total equity |
304,984 |
|
218,029 |
|
|
|
|
||
Total equity and liabilities |
755,119 |
|
585,615 |
|
|
||||||||
Consolidated Statements of Cash Flows |
||||||||
For the quarters and years ended |
||||||||
(Unaudited) |
||||||||
(Expressed in thousands of |
||||||||
|
|
|
|
|
||||
|
Quarter ended |
Year ended |
||||||
|
|
|
|
|
||||
|
$ |
$ |
$ |
$ |
||||
|
|
|
|
|
||||
CASH PROVIDED BY (USED IN) |
|
|
|
|
||||
|
|
|
|
|
||||
Operating activities |
|
|
|
|
||||
Net earnings (loss) |
(1,864 |
) |
73,061 |
|
(4,144 |
) |
77,518 |
|
Earnings from discontinued operations |
- |
|
107,391 |
|
- |
|
124,820 |
|
Loss from continuing operations |
(1,864 |
) |
(34,330 |
) |
(4,144 |
) |
(47,302 |
) |
Items not affecting cash: |
|
|
|
|
||||
Depreciation and amortization |
8,851 |
|
7,415 |
|
34,641 |
|
30,308 |
|
Amortization of debt issuance costs |
360 |
|
1,055 |
|
1,353 |
|
4,078 |
|
Deferred income taxes |
(2,744 |
) |
2,043 |
|
(2,923 |
) |
7,553 |
|
Stock-based compensation |
(493 |
) |
4,251 |
|
9,100 |
|
11,676 |
|
Impairment of long-lived assets |
244 |
|
7,803 |
|
3,206 |
|
7,803 |
|
Loss on foreign currency forward contract |
- |
|
12,658 |
|
- |
|
12,658 |
|
Loss on retirement of debt |
- |
|
8,915 |
|
- |
|
8,915 |
|
Other |
1,594 |
|
(368 |
) |
1,090 |
|
(157 |
) |
Changes in operating assets and liabilities, net of businesses sold |
13,717 |
|
10,397 |
|
(63,755 |
) |
17,131 |
|
Net cash provided by (used in) operating activities of continuing operations |
19,665 |
|
19,839 |
|
(21,432 |
) |
52,663 |
|
Net cash provided by operating activities of discontinued operations |
- |
|
14,282 |
|
- |
|
39,033 |
|
Net cash provided by (used in) operating activities |
19,665 |
|
34,121 |
|
(21,432 |
) |
91,696 |
|
|
|
|
|
|
||||
Investing activities |
|
|
|
|
||||
Additions to property, plant and equipment |
(23,308 |
) |
1,473 |
|
(58,297 |
) |
(24,754 |
) |
Additions to intangible assets |
- |
|
- |
|
(25,073 |
) |
- |
|
Proceeds from sale of assets |
- |
|
- |
|
2,300 |
|
- |
|
Cash settlement of foreign currency forward contract |
- |
|
(12,658 |
) |
- |
|
(12,658 |
) |
Other |
- |
|
- |
|
- |
|
41 |
|
Net cash used in investing activities of continuing operations |
(23,308 |
) |
(11,185 |
) |
(81,070 |
) |
(37,371 |
) |
Net cash provided by (used in) investing activities of discontinued operations |
- |
|
363,496 |
|
(13,380 |
) |
361,889 |
|
Net cash provided by (used in) investing activities |
(23,308 |
) |
352,311 |
|
(94,450 |
) |
324,518 |
|
|
|
|
|
|
||||
Financing activities |
|
|
|
|
||||
Increase (decrease) under revolving credit facilities |
(17,161 |
) |
(149,518 |
) |
106,016 |
|
(175,990 |
) |
Borrowings of long-term debt |
23,420 |
|
5,179 |
|
32,800 |
|
5,179 |
|
Repayment of long-term debt, including premium paid |
(1,882 |
) |
(229,729 |
) |
(13,671 |
) |
(231,431 |
) |
Payment of debt issuance costs |
(9 |
) |
(2,397 |
) |
(2,561 |
) |
(4,888 |
) |
Proceeds from the exercise of stock options and employee share purchases |
232 |
|
613 |
|
7,726 |
|
2,048 |
|
Payment of withholding taxes on stock-based awards |
(405 |
) |
(1,704 |
) |
(8,718 |
) |
(4,080 |
) |
Payment of cash dividends on preferred stock |
(609 |
) |
(2,378 |
) |
(5,247 |
) |
(4,078 |
) |
Payment of share issuance costs |
- |
|
- |
|
(287 |
) |
- |
|
Proceeds on issuance of preferred stock, net of issuance costs |
- |
|
- |
|
- |
|
26,804 |
|
Other |
- |
|
(181 |
) |
- |
|
(185 |
) |
Net cash provided by (used in) financing activities of continuing operations |
3,586 |
|
(380,115 |
) |
116,058 |
|
(386,621 |
) |
Net cash used in financing activities of discontinued operations |
- |
|
(7,216 |
) |
(200 |
) |
(31,063 |
) |
Net cash provided by (used in) financing activities |
3,586 |
|
(387,331 |
) |
115,858 |
|
(417,684 |
) |
|
|
|
|
|
||||
Decrease in cash and cash equivalents during the year |
(57 |
) |
(899 |
) |
(24 |
) |
(1,470 |
) |
|
|
|
|
|
||||
Cash and cash equivalents of discontinued operations: |
|
|
|
|
||||
Balance at the beginning of the period |
- |
|
678 |
|
- |
|
1,370 |
|
Foreign exchange gain on cash and cash equivalents |
- |
|
212 |
|
- |
|
223 |
|
|
|
|
|
|
||||
Cash and cash equivalent, beginning of the period |
284 |
|
260 |
|
251 |
|
128 |
|
|
|
|
|
|
||||
Cash and cash equivalents, end of the period |
227 |
|
251 |
|
227 |
|
251 |
|
|
||||||||
Segmented Information |
||||||||
For the quarters and years ended |
||||||||
Unaudited |
||||||||
(Expressed in thousands of |
||||||||
|
|
|
|
|
||||
|
Quarter ended |
Year ended |
||||||
|
|
|
|
|
||||
|
$ |
$ |
$ |
$ |
||||
Segment revenues from external customers: |
|
|
|
|
||||
|
125,074 |
|
118,179 |
|
470,754 |
|
415,164 |
|
|
79,158 |
|
87,377 |
|
341,870 |
|
374,049 |
|
Total segment revenues from external customers |
204,232 |
|
205,556 |
|
812,624 |
|
789,213 |
|
|
|
|
|
|
||||
Segment gross profit: |
|
|
|
|
||||
|
14,585 |
|
22,980 |
|
76,336 |
|
80,497 |
|
|
3,819 |
|
8,827 |
|
21,749 |
|
28,580 |
|
Total segment gross profit |
18,404 |
|
31,807 |
|
98,085 |
|
109,077 |
|
|
|
|
|
|
||||
Segment operating income (loss): |
|
|
|
|
||||
|
6,967 |
|
13,324 |
|
36,981 |
|
50,780 |
|
|
(2,462 |
) |
1,185 |
|
(9,320 |
) |
(7,321 |
) |
Corporate Services |
(6,085 |
) |
(7,696 |
) |
(17,512 |
) |
(31,151 |
) |
Total segment operating income (loss) |
(1,580 |
) |
6,813 |
|
10,149 |
|
12,308 |
|
|
|
|
|
|
||||
Segment gross profit percentage: |
|
|
|
|
||||
|
11.7 |
% |
19.4 |
% |
16.2 |
% |
19.4 |
% |
|
4.8 |
% |
10.1 |
% |
6.4 |
% |
7.6 |
% |
Total segment gross profit percentage |
9.0 |
% |
15.5 |
% |
12.1 |
% |
13.8 |
% |
|
|
|
|
|
||||
Segment operating income (loss) percentage: |
|
|
|
|
||||
|
5.6 |
% |
11.3 |
% |
7.9 |
% |
12.2 |
% |
|
-3.1 |
% |
1.4 |
% |
-2.7 |
% |
-2.0 |
% |
Total segment operating income (loss) percentage |
-0.8 |
% |
3.3 |
% |
1.2 |
% |
1.6 |
% |
Non-GAAP Measures
In addition to reporting financial results in accordance with
In order to evaluate its results of operations, the Company uses certain other non-GAAP measures that it believes enhance an investor’s ability to derive meaningful period-over-period comparisons and trends from the results of operations. In particular, the Company evaluates its revenues on a basis that excludes the effects of fluctuations in commodity pricing and the impacts of acquisitions and divestitures. In addition, the Company excludes specific items from its reported results that due to their nature or size, it does not expect to occur as part of its normal business on a regular basis. These items are identified in the tables below. These non-GAAP measures are presented solely to allow investors to more fully assess the Company’s results of operations and should not be considered in isolation of, or as substitutes for an analysis of the Company’s results as reported under
Adjusted Earnings/Loss
When assessing its financial performance, the Company uses an internal measure that excludes charges and gains that it believes are not reflective of normal operations. This information is provided to allow investors to make meaningful comparisons of the Company’s operating performance between periods and to view the Company’s business from the same perspective as the Company’s management. Adjusted earnings/loss and adjusted earnings/loss per diluted share should not be considered in isolation or as a substitute for performance measures calculated in accordance with
The following is a tabular presentation of adjusted earnings/loss and adjusted earnings/loss per diluted share, including a reconciliation from earnings/loss from continuing operations, which the Company believes to be the most directly comparable
|
|
|
|
|
|
||||
|
|
|
|
||||||
|
|
Per Share |
|
|
Per Share |
||||
For the quarter ended |
$ |
$ |
|
$ |
$ |
||||
Loss from continuing operations |
(1,864 |
) |
|
|
(34,330 |
) |
|
||
Dividends and accretion on preferred stock |
(752 |
) |
|
|
(2,855 |
) |
|
||
Loss from continuing operations attributable to common shareholders |
(2,616 |
) |
(0.02 |
) |
|
(37,185 |
) |
(0.41 |
) |
Adjusted for: |
|
|
|
|
|
||||
Business development costs(a) |
2,641 |
|
|
|
- |
|
|
||
Long-lived asset impairments and facility closure costs(b) |
1,063 |
|
|
|
2,676 |
|
|
||
Costs related to exit from fruit ingredient processing facility(c) |
902 |
|
|
|
- |
|
|
||
Start-up costs(d) |
745 |
|
|
|
1,546 |
|
|
||
Loss on foreign currency forward contract(e) |
- |
|
|
|
12,658 |
|
|
||
Loss on retirement of debt(f) |
- |
|
|
|
8,915 |
|
|
||
Restructuring costs(g) |
- |
|
|
|
8,548 |
|
|
||
Other(h) |
(26 |
) |
|
|
(732 |
) |
|
||
Net income tax effect(i) |
(3,686 |
) |
|
|
1,118 |
|
|
||
Adjusted loss |
(977 |
) |
(0.01 |
) |
|
(2,456 |
) |
(0.03 |
) |
(a) |
Represents third-party costs associated with business development activities, including costs related to the evaluation, execution, and integration of external acquisitions and divestitures, and internal expansion projects and other strategic initiatives. For the fourth quarter of 2021, these costs included the transition and integration of the acquired Dream and WestSoy brands and the exploration of other potential strategic opportunities, which were recorded in cost of goods sold ( |
|
(b) |
For the fourth quarter of 2021, mainly reflects costs related to the relocation of our executive office and innovation center into |
|
(c) |
For the fourth quarter of 2021, reflects closure costs related to the exit from our fruit ingredient processing facility, including inventory write-offs of |
|
(d) |
Represents incremental direct costs incurred in connection with plant expansion projects and new product introductions before the project or product reaches normal production levels, including costs for the hiring and training of additional personnel, fees for outside services, travel costs, and plant- and production-related expenses. For the fourth quarters of 2021 and 2020, start-up costs related to expansion projects within our plant-based beverage and ingredient operations, which were recorded in cost of goods sold. |
|
(e) |
For the fourth quarter of 2020, reflects a loss on a foreign currency forward contract to economically hedge the cash consideration from the sale of Tradin Organic, which was recorded in other expense. |
|
(f) |
For the fourth quarter of 2020, reflects the premium paid ( |
|
(g) |
For the fourth quarter of 2020, reflects professional fees of |
|
(h) |
For the fourth quarter of 2020, other includes a reversal of previously accrued costs related to the withdrawal of certain consumer-packaged products, which was recorded in other income/expense. |
|
(i) |
Reflects the tax effect of the preceding adjustments to earnings calculated based on our estimated annual effective tax rate. |
|
|
|
|
|
|||||
|
|
|
|
||||||
|
|
Per Share |
|
|
Per Share |
||||
For the years ended |
$ |
$ |
|
$ |
$ |
||||
Loss from continuing operations |
(4,144 |
) |
|
|
(47,302 |
) |
|
||
Dividends and accretion on preferred stock |
(4,197 |
) |
|
|
(10,328 |
) |
|
||
Loss from continuing operations attributable to common shareholders |
(8,341 |
) |
(0.08 |
) |
|
(57,630 |
) |
(0.65 |
) |
Adjusted for: |
|
|
|
|
|
||||
Business development costs(a) |
6,209 |
|
|
|
- |
|
|
||
Costs related to exit from fruit ingredient processing facility(b) |
5,504 |
|
|
|
- |
|
|
||
Restructuring costs(c) |
1,432 |
|
|
|
9,897 |
|
|
||
Long-lived asset impairments and facility closure costs(d) |
1,063 |
|
|
|
2,676 |
|
|
||
Start-up costs(e) |
745 |
|
|
|
1,883 |
|
|
||
Workforce reduction charges(f) |
499 |
|
|
|
- |
|
|
||
Loss on foreign currency forward contract(g) |
- |
|
|
|
12,658 |
|
|
||
Loss on retirement of debt(h) |
- |
|
|
|
8,915 |
|
|
||
Other(i) |
261 |
|
|
|
(189 |
) |
|
||
Net income tax effect(j) |
(5,827 |
) |
|
|
255 |
|
|
||
Adjusted earnings (loss) |
1,545 |
|
0.01 |
|
|
(21,535 |
) |
(0.24 |
) |
|
|
|
|
|
|
||||
(a) |
Represents third-party costs associated with business development activities, including costs related to the evaluation, execution, and integration of external acquisitions and divestitures, and internal expansion projects and other strategic initiatives. For 2021, these costs included the transition and integration of the acquired Dream and WestSoy brands, project development activities related to our new plant-based beverage facility under construction in |
|
(b) |
For 2021, reflects closure costs related to the exit from our fruit ingredient processing facility, including long-lived asset impairment charges ( |
|
(c) |
For 2021, represents costs to complete the exit from our |
|
(d) |
For 2021, mainly reflects costs related to the relocation of our executive office and innovation center into |
|
(e) |
Represents incremental direct costs incurred in connection with plant expansion projects and new product introductions before the project or product reaches normal production levels, including costs for the hiring and training of additional personnel, fees for outside services, travel costs, and plant- and production-related expenses. For 2021 and 2020, start-up costs related to expansion projects within our plant-based beverage and ingredient operations, which were recorded in cost of goods sold. |
|
(f) |
For 2021, represents severance and related benefit charges related to workforce reduction actions in our frozen fruit operations to reduce overhead costs, which were recorded in other expense. |
|
(g) |
For 2020, reflects a loss on a foreign currency forward contract to economically hedge the cash consideration from the sale of Tradin Organic, which was recorded in other expense. |
|
(h) |
For 2020, reflects the premium paid ( |
|
(i) |
For 2021, other includes a |
|
(j) |
Reflects the tax effect of the preceding adjustments to earnings calculated based on our estimated annual effective tax rate. |
Segment Operating Income/Loss and Adjusted EBITDA
The Company defines segment operating income/loss as net earnings/loss before income taxes, interest expense and other income/expense items, and adjusted EBITDA as segment operating income/loss plus depreciation, amortization, non-cash stock-based compensation, and other unusual items that affect the comparability of operating performance as identified above in the determination of adjusted earnings/loss. The following is a tabular presentation of segment operating income/loss and adjusted EBITDA, including a reconciliation to earnings/loss from continuing operations, which the Company believes to be the most directly comparable
|
|
|
|
||
For the quarter ended |
$ |
|
$ |
||
Loss from continuing operations |
(1,864 |
) |
|
(34,330 |
) |
Income tax expense (benefit) |
(3,782 |
) |
|
2,019 |
|
Loss on retirement of debt(a) |
- |
|
|
8,915 |
|
Interest expense, net |
2,624 |
|
|
7,605 |
|
Other expense, net |
1,442 |
|
|
22,604 |
|
Total segment operating income (loss) |
(1,580 |
) |
|
6,813 |
|
Depreciation and amortization |
8,851 |
|
|
7,415 |
|
Stock-based compensation(b) |
(493 |
) |
|
4,250 |
|
Business development costs(c) |
2,566 |
|
|
- |
|
Start-up costs(d) |
745 |
|
|
1,546 |
|
Costs related to exit from fruit ingredient processing facility(e) |
572 |
|
|
- |
|
Restructuring costs(f) |
- |
|
|
546 |
|
Adjusted EBITDA |
10,661 |
|
|
20,570 |
|
(a) |
For the fourth quarter of 2020, reflects the premium paid ( |
|
(b) |
For the fourth quarter of 2021, reflects the reversal of stock-based compensation for unvested awards granted under the Company’s short-term incentive plan based on financial performance. |
|
(c) |
For the fourth quarter of 2021, third-party business development costs reflected the transition and integration of the acquired Dream and WestSoy brands, and the exploration of other potential strategic opportunities, which were recorded in cost of goods sold ( |
|
(d) |
For fourth quarters of 2021 and 2020, reflects start-up costs related to expansion projects within our plant-based beverage and ingredient operations, which were recorded in cost of goods sold. |
|
(e) |
For the fourth quarter of 2021, reflects inventory write-offs related to the exit from our fruit ingredient processing facility, which were recorded in cost of goods sold. |
|
(f) |
For the fourth quarter of 2020, reflects professional fees of |
|
|
|
|||
For the years ended |
$ |
|
$ |
||
Loss from continuing operations |
(4,144 |
) |
|
(47,302 |
) |
Income tax benefit |
(3,366 |
) |
|
(2,740 |
) |
Loss on retirement of debt(a) |
- |
|
|
8,915 |
|
Interest expense, net |
8,769 |
|
|
30,042 |
|
Other expense, net |
8,890 |
|
|
23,393 |
|
Total segment operating income |
10,149 |
|
|
12,308 |
|
Depreciation and amortization |
34,641 |
|
|
30,308 |
|
Stock-based compensation(b) |
9,100 |
|
|
12,570 |
|
Business development costs(c) |
5,506 |
|
|
- |
|
Start-up costs(d) |
745 |
|
|
1,883 |
|
Costs related to exit from fruit ingredient processing facility(e) |
572 |
|
|
- |
|
Restructuring costs(f) |
- |
|
|
1,649 |
|
Adjusted EBITDA |
60,713 |
|
|
58,718 |
|
(a) |
For 2020, reflects the premium paid ( |
|
(b) |
For 2020, stock-based compensation of |
|
(c) |
For 2021, third-party business development costs reflected the transition and integration of the acquired Dream and WestSoy brands, project development activities related to our new plant-based beverage facility under construction in |
|
(d) |
For 2021 and 2020, reflects start-up costs related to expansion projects within our plant-based beverage and ingredient operations, which were recorded in cost of goods sold. |
|
(e) |
For 2021, reflects inventory write-offs related to the exit from our fruit ingredient processing facility, which were recorded in cost of goods sold. |
|
(f) |
For 2020, reflects professional fees of |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220224005366/en/
ICR
646-277-1260
reed.anderson@icrinc.com
Source:
FAQ
What were SunOpta's Q4 2021 earnings results for stock symbol STKL?
What is SunOpta's revenue guidance for fiscal year 2022?
What challenges did SunOpta face in Q4 2021?
How did SunOpta's plant-based revenue perform in Q4 2021?
